Association between serum adipocyte factor level and insulin resistance in polycystic ovarian syndrome

References

• Galluzzo A, Amato MC, Giordano C. Insulin resistance and polycystic ovary syndrome. Nutri Metab Cardiovasc Dis 2008;18:511–518.
   PubMed Web of Science ®Google Scholar
• Teede HJ, Hutchison S, Zoungas S, Meyer C. Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS. Endocrine 2006;30: 45–53.
   PubMed Web of Science ®Google Scholar
• Carmina E, Orio F, Palomba S, Cascella T, Longo RA, Colao AM, Lombardi G, Lobo RA. Evidence for altered adipocyte function in polycystic ovary syndrome. Eur J Endocrinol 2005;152:389–394.
   PubMed Web of Science ®Google Scholar
• Shuldiner AR, Yang R, Gong DW. Resistin, obesity, and insulin resistance the emerging role of the adipocyte as an endocrine organ. N Engl J Med 2001;345:1345–1346.
   PubMed Web of Science ®Google Scholar
• Dunaif A. Polycystic ovary syndrome and obesity. ObesityIn: Bjorntorp P, Brodoff BN, editors. Philadelphia: J.B. Lippincott Co1992. pp 594–605.
   Google Scholar
• Atamer A, Demir B, Bayhan G, Atamer Y, Ilhan N, Akkus Z. Serum levels of leptin and homocysteine in women with polycystic ovary syndrome and its relationship to endocrine, clinical and metabolic parameters. J Int Med Res 2008;36:96–105.
   PubMed Web of Science ®Google Scholar
• Erturk E, Kuru N, Savci V, Tuncel E, Ersoy C, Imamoglu S. Serum leptin levels correlate with obesity parameters but not with hyperinsulinism in women with polycystic ovary syndrome. Fertil Steril 2004;82:1364–1368.
   PubMed Web of Science ®Google Scholar
• Xita N, Papassotiriou I, Georgiou I, Vounatsou M, Margeli A, Tsatsoulis A. The adiponectin-to-leptin ratio in women with polycystic ovary syndrome: relation to insulin resistance and proinflammatory markers. Metabolism 2007;56:766–771.
   PubMed Web of Science ®Google Scholar
• Pehlivanov B, Mitkov M. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome. Eur J Contracept Reprod Health Care 2009;14:153–159.
   PubMed Web of Science ®Google Scholar
• Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995;83:1263–1271.
   PubMed Web of Science ®Google Scholar
• Hahn S, Haselhorst U, Quadbeck B, Tan S, Kimmig R, Mann K, Janssen OE. Decreased soluble leptin receptor levels in women with polycystic ovary syndrome. Eur J Endocrinol 2006;154:287–294.
   PubMed Web of Science ®Google Scholar
• Sepilian VP, Crochet JR, Nagamani M. Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens. Fertil Steril 2006;85:1441–1447.
   PubMed Web of Science ®Google Scholar
• Romualdi D, Campagna G, Selvaggi L Jr, Cento R, Proto C, Lanzone A, Guido M. Metformin treatment does not affect total leptin levels and free leptin index in obese patients with polycystic ovary syndrome. Fertil Steril 2008;89:1273–1276.
   PubMed Web of Science ®Google Scholar
• Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature 2001;409:307–312.
   PubMed Web of Science ®Google Scholar
• Panidis D, Koliakos G, Kourtis A, Farmakiotis D, Mouslech T, Rousso D. Serum resistin levels in women with polycystic ovary syndrome. Fertil Steril 2004;81:361–366.
   PubMed Web of Science ®Google Scholar
• Xita N, Georgiou I, Tsatsoulis A, Kourtis A, Kukuvitis A, Panidis D. A polymorphism in the resistin gene promoter is associated with body mass index in women with polycystic ovary syndrome. Fertil Steril 2004;82:1466–1467.
   PubMed Web of Science ®Google Scholar
• Ouchi N, Kihara S, Arita Y. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived acrophages. Circulation 2001;103:1057–1063.
   PubMed Web of Science ®Google Scholar
• Stefan N, Stumvoll M. Adiponectin—its role in metabolism and beyond. Horm Metab Res, 2002;34:469–474.
   PubMed Web of Science ®Google Scholar
• Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinaemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930–1935.
   PubMed Web of Science ®Google Scholar
• Gulcelik NE, Aral Y, Serter R, Demir Y, Culha C. Adiponectin is an independent determinant of insulin resistance in women with polycystic ovary syndrome. Gynecol Endocrinol 2006;22:511–515.
   PubMed Web of Science ®Google Scholar
• Toulis KA, Goulis DG, Farmakiotis D, Georgopoulos NA, Katsikis I, Tarlatzis BC, Papadimas I, Panidis D. Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Hum Reprod Update 2009;15:297–307.
   PubMed Web of Science ®Google Scholar
• Orio F Jr, Palomba S, Cascella T, Milan G, Mioni R, Pagano C, Zullo F, Colao A, Lombardi G, Vettor R. Adiponectin levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:2619–2623.
   PubMedGoogle Scholar
• Yilmaz M, Bukan N, Demirci H, Ozturk C, Kan E, Ayvaz G, Arslan M. Serum resistin and adiponectin levels in women with polycystic ovary syndrome. Gynecol Endocrinol 2009;25:246–252.
   PubMed Web of Science ®Google Scholar
• Majuri A, Santaniemi M, Rautio K, Kunnari A, Vartiainen J, Ruokonen A, Kesaniemi YA, Tapanainen JS, Ukkola O, Morin-Papunen L. Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study. Eur J Endocrinol 2007;156:263–269.
   PubMed Web of Science ®Google Scholar